Phil Wolfson, MD, and Julane Andries, MFT MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness
28:25 min
CLEAR ALL
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
1
Psychedelic drugs: a dangerous and illegal scourge; a harmless way to “turn on, tune in, drop out” – or a valuable treatment for mental illness? Research is showing that substances like MDMA and magic mushrooms, long banished to society’s fringes, are proving effective in treating...
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
A small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results.
By the mid-1950s, LSD research was being published in medical and academic journals all over the world. It showed potential benefits in the treatment of alcoholism, drug addiction, and other mental illnesses. This film explores those potential benefits, and the researchers who explored them.
Mark Haden will explore the history and current research and possible future regulation of psychedelics. He will begin with an overview of indigenous history then explore the history in Canada and why psychedelics were criminalized.
Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.
A renaissance is underway in the scientific study of psychedelics, both as a mode of therapy for mental illness and as a tool for understanding the mind.
New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression.